A股異動丨金太陽(300606.SZ)大漲超9% 正式取得富士康科技集團供應商代碼
格隆匯5月21日丨金太陽(300606.SZ)大漲超9%,報18.4元,總市值17億元。金太陽公佈,公司近日取得富士康科技集團供應商代碼並收到中標通知。經過嚴格的產品質量驗證以及供應商審核,公司正式取得富士康科技集團供應商代碼,主要為其旗下各分子公司提供拋光材料、拋光設備等產品和技術服務。此次取得富士康供應商代碼及中標通知表明公司與富士康的合作進一步加深,將對公司未來的經營業績產生積極影響,同時該項目開展不影響公司業務的獨立性。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.